EGFR upregulation was also confirmed in lung squamous cell carcinoma (LUSC, fold change of cancer vs. normal = 3.15, p < 0.001) and kidney renal clear cell carcinoma (KIRC, fold change of cancer vs. normal = 2.25, p < 0.001) using publicly available data from TCGA and following the relevant algorithms (http://starbase.sysu.edu.cn (accessed on 12 October 2022), Figure S1). The gene discussed is EGFR; the disease is cancer.